These results indicate that there are distinct prognostic values of PRDX family members in patients with ovarian cancer, and that the expression of PRDX3, PRDX5, and PRDX6 mRNAs is closely associated with prognostic predictors of the effect of chemotherapy in ovarian cancer patients. The gene discussed is PRDX3; the disease is ovarian carcinoma.